Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage have propelled their returns.
But not every company with momentum is a long-term winner, and plenty of investors have lost money betting on short-term fads. Keeping that in mind, here are three stocks with the fundamentals to back up their performance.
Rocket Lab (RKLB)
One-Month Return: +25.6%
Becoming the first private company in the Southern Hemisphere to reach space, Rocket Lab (NASDAQ:RKLB) offers rockets designed for launching small satellites.
Why Does RKLB Stand Out?
- Annual revenue growth of 56.9% over the last two years was superb and indicates its market share increased during this cycle
- Market share will likely rise over the next 12 months as its expected revenue growth of 42.3% is robust
- Historical investments are beginning to pay off as its returns on capital are growing
At $84.45 per share, Rocket Lab trades at 55.4x forward price-to-sales. Is now the time to initiate a position? See for yourself in our full research report, it’s free.
VSE Corporation (VSEC)
One-Month Return: +27.7%
With roots dating back to 1959 and a strategic focus on extending the life of transportation assets, VSE Corporation (NASDAQ:VSEC) provides aftermarket parts distribution and maintenance, repair, and overhaul services for aircraft and vehicle fleets in commercial and government markets.
Why Do We Watch VSEC?
- Impressive 13.7% annual revenue growth over the last two years indicates it’s winning market share this cycle
- Exciting sales outlook for the upcoming 12 months calls for 43.9% growth, an acceleration from its two-year trend
- Operating margin expanded by 5.2 percentage points over the last five years as it scaled and became more efficient
VSE Corporation is trading at $226.52 per share, or 48.2x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
Oscar Health (OSCR)
One-Month Return: +24.7%
Founded in 2012 to simplify the notoriously complex American healthcare system, Oscar Health (NYSE:OSCR) is a technology-focused health insurance company that offers individual and small group health plans through its cloud-native platform.
Why Should You Buy OSCR?
- Impressive 41.2% annual revenue growth over the last two years indicates it’s winning market share this cycle
- Adjusted operating profits increased over the last five years as the company gained some leverage on its fixed costs and became more efficient
- Free cash flow margin expanded by 16.7 percentage points over the last five years, providing additional flexibility for investments and share buybacks/dividends
Oscar Health’s stock price of $15.75 implies a valuation ratio of 31.9x forward P/E. Is now the right time to buy? See for yourself in our in-depth research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.